Distinctions of the neonatal immune system

Central-European Journal of Immunology

Volumn 35, Issue 4, 2010, Pages 252-258

  Stasiak Barmuta, Anna ^a   Stankiewicz, Wanda ^b   Da̧browski, Maciej I ^b   Jurkiewicz, Beata ^b   Da̧browski, Marek P ^b  

^a MEDICAL UNIVERSITY OF BIALYSTOK   (Poland)

^b MILITARY INSTITUTE OF HYGIENE AND EPIDEMIOLOGY   (Poland)

Author keywords

Adult immunity; Differences; Neonatal immunity

Indexed keywords

ACTIN; ALPHA INTERFERON; ANTIBIOTIC AGENT; BCG VACCINE; CD11B ANTIGEN; CD18 ANTIGEN; CD40 LIGAND; CELL SURFACE RECEPTOR; COMPLEMENT COMPONENT C3A; COMPLEMENT COMPONENT C3B; COMPLEMENT COMPONENT C4B; COMPLEMENT COMPONENT C5A; COMPLEMENT COMPONENT C5B; FIBRONECTIN; GUANINE NUCLEOTIDE BINDING PROTEIN; IMMUNOGLOBULIN; IMMUNOGLOBULIN G1; INTERLEUKIN 1; INTERLEUKIN 1 RECEPTOR ASSOCIATED KINASE 4; INTERLEUKIN 10; INTERLEUKIN 2; L SELECTIN; LECTIN; PROPERDIN; TOLL LIKE RECEPTOR 2; TOLL LIKE RECEPTOR 6; TOLL LIKE RECEPTOR 7; TRANSFORMING GROWTH FACTOR BETA; TUMOR NECROSIS FACTOR; UNINDEXED DRUG;

BACTERIAL INFECTION; BCG VACCINATION; CAMPYLOBACTER; CD4+ T LYMPHOCYTE; CD8+ T LYMPHOCYTE; CYTOMEGALOVIRUS INFECTION; DENDRITIC CELL; ENTEROTOXIGENIC ESCHERICHIA COLI; GIARDIA LAMBLIA; HERPES VIRUS INFECTION; HUMAN; IMMUNE DEFICIENCY; IMMUNE RESPONSE; IMMUNE SYSTEM; IMMUNIZATION; MACROPHAGE; MONOCYTE; NEUTROPENIA; NEUTROPHIL; PHAGOCYTOSIS; PHENOTYPE; REVIEW; SHIGELLA; STEM CELL; TUBERCULOSIS; VIBRIO CHOLERAE;

EID: 78751556206     PISSN: 14263912     EISSN: 16444124     Source Type: Journal    
DOI: None     Document Type: Review

References (65)

1. Abughali N, Berger M, Tosi MF (1994): Deficient total cell content of CR3 (C11b) in neonatal neutrophils. Blood 83: 1086-1092.
2. Adkins B, Leclerc C, Marshall-Clarke S (2004): Neonatal adaptive immunity comes of age. Nature Rev Immunol 4: 553-564.
3. Da̧browski MP (2006): Grasica, Odporność, Zdrowie. Wyd. Triangulum M.B.P., Wrocław.
4. Goldblum R, Hanson LA, Brandzberg P (1996): The mucosal defense system. In Immunological Disorders in Infants and Children. 3rd edit. E. Stiehm, Ed.: Saunders. Philadelphia, PA22, 159-199.
5. Burchett SK, Corey L, Mohan KM, et al. (1992): Diminished interferon-gamma and lymphocyte proliferation in neonatal and postpartum primary herpes simplex virus infection. J Infect Dis 165: 813-818.
6. WHO report (2004): Prevention and care of illness. Neonates and infants newborn health and survival. A call to action.
7. Anderson DC, Abbassi O, Kishimoto TK, et al. (1991): Diminished lectin, epidermal growth factor, complement binding domain cell adhesion molecule-1 on neonatal neutrophils underlies their impaired CD18-independent adhesion to endothelial cells in vitro. J Immunol 146: 3372-3379.
8. Anderson DC, Freeman KL, Heerdt B, et al. (1987): Abnormal stimulated adherence of neonatal granulocytes: impaired induction of surface Mac-1 by chemotactic factors or secretagogues. Blood 70: 740-750.
9. Geissler K, Geissler W, Hinterberger W, et al. (1986): Circulating committed and pluripotent haemopoietic progenitor cells in infants. Acta Haematol 75: 18-22.
10. Baley JE, Stork EK, Warkentin PI, et al. (1988): Neonatal neutropenia. Am J Dis Child 142: 1161-1166.
11. Christensen RD, Rothstein G (1980): Exhaustion of mature marrow neutrophils in neonates with sepsis. J Pediatr 96: 316-318.
12. Christensen RD (1988): Developmental changes in pluripotent hematopoietic progenitors. Early Hum Dev 16: 195-205.
13. Christensen RD (1989): Neutrophil kinetics in the fetus and neonate. Am J Pediatr Hematol Oncol 11: 215-223.
14. Dyke MP, Forsyth KD (1994): Plasma fibronectin levels in extremely preterm infants in the first 8 weeks of life. J Paediatr Child Health 30: 36-39.
15. Elass E (2002): Lactoferrin inhibits the lipopolysaccharide-induced expression and proteoglycan-binding ability of interleukin-8 in human endothelial cells. Infect Immun 70: 1860-1866.
16. Graf JM, Smith CW, Mariscalco MM (1996): Contribution of LFA-1 and Mac-1 to CD18-dependent neutrophil emigration in a neonatal rabbit model. J Appl Physiol 80: 1984-1992.
17. Christensen RD, Hill HR, Rothstein G (1983): Granulocytic stem cell (CFUc) proliferation in experimental group B streptococcal sepsis. Pediatr Res 17: 278-280.
18. Kim SK, Keeney SE, Alpard SK, Schmalstieg FC (2003): Comparison of L-selectin and CD11b on neutrophils of adults and neonates during the first month of life. Pediatr Res 53: 132-136.
19. Fehervari Z, Sakaguchi S (2004): CD4+ Tregs and immune control. J Clin Invest 114: 1209-1217.
20. Han P, McDonald T, Hodge G (2004): Potential immaturity of the Tcell and antigen-presenting cell interaction in cord blood with particular emphasis on the CD40-CD40 ligand costimulatory pathway.Immunology 113: 26-34.
21. Harris MC, Shalit M, Southwick FS (1993): Diminished action polymerization by neutrophils from newborn infants. Pediatr Res 33: 27-31.
22. Karlsson H, Hessle C, Rudin A (2002): Innate immune responses of human neonatal cells to bacteria from the normal gastrointestinal flora. Infect Immun 70: 6688-6696.
23. Koenig JM, Simon J, Anderson DC, et al. (1996): Diminished soluble and total cellular L-selectin in cord blond is associated with its impaired shedding from activated neutrophils. Pediatr Res 39: 616-621. (Pubitemid 26128148)
24. Manroe BL, Weinberg AG, Rosenfeld CR, et al. (1979): The neonatal blood count in health and disease: I. Reference values for neutrophilic cells. J Pediatr 95: 89-99.
25. Makhseed M (2001): Th1 and Th2 cytokine profiles In recurrent aborters with successful pregnancy and with subsequent abortions. Hum Reprod 16: 2219-2226.
26. Marchant A, Goldman M (2005): T cell-mediated immune responses in human newborns: ready to learn? Clin Exp Immunol 141: 10-18.
27. Marodi L (2006): Neonatal innate immunity to infectious agents. Infect Immun 74: 1999-2006.
28. Krishnan S, Craven M, Welliver RC, et al. (2003): Differences in participation of innate and adaptive immunity to respiratory syncytial virus in adults and neonates. J Infect Disease 188: 433-439.
29. Philbin VJ, Levy O (2009): Developmental biology of the innate immune response: implications for neonatal and infant vaccine development. Pediatr Res 65: 98-105.
30. Schonland SO, Zimmer JK, Lopez-Benitez CM, et al. (2003): Homeostatic control of T-cell generation in neonates. Blood 102: 1428-1434.
31. Szekeres-Bartho J, Faust Z, Varga P, et al. (1996): The immunological pregnancy protective effect of progesterone is manifested via controlling cytokine production. Am J Reprod Immunol 35: 348-351.
32. Hazenberg MD, Otto SA, van Rossum AM, et al. (2004): Establishment of the CD4 + T-cell pool in healthy children and untreated children infected with HIV-1. Blood 104: 3513-3519.
33. Hodge S, Hodge G, Flower R, et al. (2001): Cord blood leucocyte expression of functionally significant molecules involved in the regulation of cellular immunity. Scand J Immunol 53: 72-78.
34. Hussey GD, Watkins ML, Goddard EA, et al. (2002): Neonatal mycobacterial specific cytotoxic T-lymphocyte and cytokine profiles in response to distinct BCG vaccination strategies. Immunology 105: 314-324.
35. Kaminski BA, Kadereit S, Miller RE, et al. (2003): Reduced expression of NFAT-associated genes in UCB versus adult CD4+ T lymphocytes during primary stimulation. Blood 102: 4608-4617.
36. Klein J, Remington J (2001): In: Infectious Diseases of the Fetus and Newborn Infant eds Remington J, Klein J, W. B. Saunders Company, Philadelphia 1-23.
37. Koenig JM, Luttge B, Benson NA, et al. (2001): Cell cycle status of CD34 + cells in human fetal bone marrow. Early Hum Dev 65: 159-163.
38. Strunk T, Temming P, Gembruch U, et al. (2004): Differential maturation of the innate immune response in human fetuses, Pediatr Res 56: 219-226.
39. Tu W, Chen S, Sharp M, et al. (2004): Persistent and selective deficiency of CD41 T cell immunity to cytomegalovirus in immunocompetent young children. J Immunol 172: 3260-3267.
40. Yan SR, Qing G, Byers DM, et al. (2004): Role of MyD88 in diminished tumor necrosis factor alpha production by newborn mononuclear cells in response to lipopolysaccharide. Infect Immun 72: 1223-1229. (Pubitemid 38263739)
41. Wynn JL, Levy O (2010): Role of innate host defenses in susceptibility to early-onset neonatal sepsis. Clin Perinatol 37: 307-337.
42. Mouzinho A, Rosenfeld CR, Sanchez PJ, et al. (1994): Revised reference ranges for circulating neutrophils in very-low-birthweight neonates. Pediatrics 94: 76-82.
43. Mingari MC, Maggi E, Cambiaggi A, et al. (1996): Development in vitro of human CD4+ thymocytes into functionally mature Th2 cells. Exogenous interleukin-12 is required for priming thymocytes to produce both Th1 cytokines and interleukin-10. Eur J Immunol 26: 1083-1087.
44. Olaussen RW, Farstad IN, Brandtzaeg P, et al. (2001): Age-relatedchanges in CCR9+ circulating lymphocytes: are CCR9+ naive Tcells recent thymic emigrants? Scand J Immunol 54: 435-439.
45. Upham JW, Lee PT, Holt BJ, et al. (2002): Development of interleukin-12- producing capacity throughout childhood. Infect Immun 70: 6583-6588.
46. Serra P, Amrani A, Yamanouchi J, et al. (2003): CD40 ligation releases immature dendritic cells from the control of regulatory CD4+CD25+ T cells. Immunity 19: 877-889.
47. Wessels MR (2004): Selective impairment of TLR-mediated innate immunity in human newborns: neonatal blood plasma reduces monocyte TNF-alpha induction by bacterial lipopeptides, lipopolysaccharide, and imiquimod, but preserves the response to R-848. J Immunol 173: 4627-4634.
48. Wu L, Liu Y J (2007): Development of dendritic-cell lineages. Immunity 26: 741-750.
49. Wallet MA, Sen P, Tisch R (2005): Immunoregulation of dendritic cells. Clin Med Res 3: 166-175.
50. Sonntag J, Brandenburg U, Polzehl D, et al. (1998): Complement system in health term newborns: reference values in umbilical cord blood. Pediatr Dev Pathol 1: 131-135.
51. White GP, Watt PM, Holt BJ, et al. (2002): Differential patterns of methylation of the IFN-gamma promoter at CpG and non- CpG sites underlie differences in IFN-gamma gene expression between human neonatal and adult CD45RO- T cells. J Immunol 168: 2820-2827.
52. Englund JA, Glezen WP (1991): Maternal immunization for the prevention of infection in early infancy. Semin Pediatric Infectious Diseases 2: 225-231.
53. Levings M, Sangregorio KR, Galbiati F, et al. (2001): IFN-alpha and IL-10 induce the differentiation of human type 1 T regulatory cells. J Immunol 166: 5530-5539.
54. Burg ND, Pillinger MH (2001): The neutrophil: function and regulation in innate and humoral immunity. Clin Immunol 99: 7-17.
55. Fadel SA, Ozaki DA, Sarzotti M (2002): Enhanced type 1 immunity after secondary viral challenge in mice primed as neonates. J Immunol 169: 3293-3300.
56. Siegrist CA (2001): Neonatal and early life vaccinology. Vaccine 19: 3331-3346.
57. Firth MA, Shewen PE, Hodgins DC (2005): Passive and active components of neonatal innate immune defenses. Anim Health Res Rev 6: 143-158.
58. Wright PF (1998): Infectious diseases in early life in industrialized countries. Vaccine 16: 1355-1359.
59. Siegrist CA, Saddallah F, Tougne C, et al. (1998): Induction of neonatal TH1 and CTL responses by live viral vaccines: a role for replication patterns within antigen presenting cells? Vaccine 16: 1473-1478.
60. Hassan J, Reen DJ (1998): IL-7 promotes the survival and maturation but not differentiation of human post-thymic CD4 +T cells. Eur J Immunol 28: 3057-3065.
61. Godfrey WR, Spoden DJ, Ge YG, et al. (2004): Cord blood CD4+CD25+ derived T regulatory cell lines express FoxP3 protein and manifest potent suppressor function. Blood 105: 750-758.
62. Baker CJ, Rench MA, Noya FJ, et al. (1990): Role of intravenous immunoglobulin in prevention of late-onset infection in low-birth-weight neonatans. Rev Infect Dis 12: S463-468
63. Hayward A, Herberger MJ, Groothuis J, et al. (1984): Specific immunity after congenital or neonatal infection with cytomegalovirus or herpes simplex virus. J Immunol 133: 2469-2473. (Pubitemid 15204770)
64. Marchini G (2005): Erythema toxicum neonatorum is an innate immune response to commensal microbes penetrated into the skin of the newborn infant. Pediatr Res 58: 613-616.
65. Flanagan KL, Burl S, Lohman-Payne BL, et al. (2010): The challenge of assessing infant vaccine responses in resource-poor settings. Expert Rev Vaccines 9: 665-674.